Zum Hauptinhalt springen

Spastic paraplegia type 3A

Spastic paraplegia type 3A is one of a group of genetic disorders known as hereditary spastic paraplegias. These disorders are characterised by muscle stiffness (spasticity) and weakness in the lower limbs (paraplegia). Hereditary spastic paraplegias are often divided into two types: pure and complex. The pure types involve only the lower limbs, while the complex types also involve other areas of the body; additional features can include changes in vision, changes in intellectual functioning, difficulty walking, and disturbances in nerve function (neuropathy). Spastic paraplegia type 3A is usually a pure hereditary spastic paraplegia, although a few complex cases have been reported.

Beschreibung

Spastic paraplegia type 3A is one of a group of genetic disorders known as hereditary spastic paraplegias. These disorders are characterised by muscle stiffness (spasticity) and weakness in the lower limbs (paraplegia). Hereditary spastic paraplegias are often divided into two types: pure and complex. The pure types involve only the lower limbs, while the complex types also involve other areas of the body; additional features can include changes in vision, changes in intellectual functioning, difficulty walking, and disturbances in nerve function (neuropathy). Spastic paraplegia type 3A is usually a pure hereditary spastic paraplegia, although a few complex cases have been reported.

In addition to spasticity and weakness, which typically affect both legs equally, people with spastic paraplegia type 3A can also experience progressive muscle wasting (amyotrophy) in the lower limbs, reduced bladder control, an abnormal curvature of the spine (scoliosis), loss of sensation in the feet (peripheral neuropathy), or high arches of the feet (pes cavus). The signs and symptoms of spastic paraplegia type 3A usually appear before the age of 10; the average age of onset is 4 years. In some affected individuals the condition slowly worsens over time, sometimes leading to a need for walking support.

Inheritance patterns

The source lists the following possible inheritance patterns: Autosomal dominant. More than one pattern can apply in different cases.

Other names

Spastic paraplegia 3

Spastic paraplegia 3A

SPG3A

Related patient information and medicines

Zerebralparese

Patient information leaflet

Zerebralparese

This may be before the baby is born, during the birth or soon after birth. What is cerebral palsy. Cerebral palsy is a name for a group of life-long conditions that have problems with muscle function and control. It is caused by brain injury or abnormal development of the brain that occurs while a child's brain is still developing. Types of.

Dystonie

Patient information leaflet

Dystonie

A Dystonie is a lasting or frequently recurring and unwanted (involuntary) muscle contraction. It can affect one or more muscles in the body. There is no cure; however, there are different types of treatment which can help. Secondary dystonia Secondary means the dystonia ... It is not caused by your genetic make-up. Some neurological conditions.

Nervenschäden nach Epiduralinjektion

Patient information leaflet

Nervenschäden nach Epiduralinjektion

A spinal injection Spinal anaesthetic is given directly into the fluid that surrounds your spinales cord (called the cerebrospinal fluid). The injection can be a local anaesthetic or a medicine to relieve pain. The risk of longer... Nervenschäden to both legs (paraplegia) or death occurs between 1 in 54,500 to 1 in 141,500 spinales or epidural.

Epidurale Schmerzbehandlung nach der Operation

Patient information leaflet

Epidurale Schmerzbehandlung nach der Operation

The content of this leaflet is used with the permission of the Royal College of Anaesthetists , the professional body responsible for the speciality throughout the UK, ensuring the quality of patient care through the maintenance of standards in anaesthesia, critical care and pain medicine. What is an epidural. An epidural is used for giving pain.

Muskeldystrophie

Patient information leaflet

Muskeldystrophie

Einige genes control the proteins needed for muscle fibres to work properly. Genetic mutations can affect these genes, which are involved in MD. The 'faulty' gene in MD means that one of the proteins needed by muscle cells cannot be made correctly. The protein will either be lacking or will be a 'faulty' protein that does not work well. This leads.

Morbus Paget des Knochens

Patient information leaflet

Morbus Paget des Knochens

Paget's disease of bone affects the structure of parts of one or more bones. In most cases it causes no symptoms and does not need treatment. Symptoms develop in some cases and pain in the affected part of bone... What is Paget's disease of bone. Paget's disease of bone was first described by Sir James Paget in 1877. (It is a different condition.

Weiterführende Lektüre und Referenzen

Artikelverlauf

Die Informationen auf dieser Seite werden von qualifizierten Klinikern verfasst und begutachtet.
  • 27 Apr 2021 | Neueste Version
  • 1 Mar 2015 | Ursprünglich veröffentlicht

Nehmen Sie an der Diskussion teil

Teilen Sie Ihre Gedanken oder Erfahrungen mit anderen in unserem Patientengemeinschaften.

Haftungsausschluss: The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.

Online-Apotheke, Behandlungen und Gesundheitsdienstleistungen

Einfacher Zugang zu vertrauenswürdigen Behandlungen und Gesundheitsdiensten online.

Common conditions

Get help with common conditions through the NHS, without a GP appointment.

Book your free Pharmacy First appointment

Abonnieren Sie den Patienten-Newsletter

Ihre wöchentliche Dosis klarer, vertrauenswürdiger Gesundheitsberatung - geschrieben, um Ihnen zu helfen, sich informiert, selbstbewusst und in Kontrolle zu fühlen.

Bitte geben Sie eine gültige E-Mail-Adresse ein

Durch das Abonnieren akzeptieren Sie unsere Datenschutzrichtlinie. Sie können sich jederzeit abmelden. Wir verkaufen Ihre Daten niemals.